Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
about
The aggressive peripheral T-cell lymphomas: 2013Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosisExtranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.T-cell lymphomas, a challenging disease: types, treatments, and future.High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149.Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.Prognostic markers in peripheral T-cell lymphomaExtranodal natural-killer/t-cell lymphoma, nasal typeAnti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphomaThe heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas.A TNM Staging System for Nasal NK/T-Cell Lymphoma.Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.Primary Intestinal Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Comprehensive Clinicopathological Analysis of 55 Cases.Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2A Case of Mature Natural Killer-Cell Neoplasm Manifesting Multiple Choroidal Lesions: Primary Intraocular Natural Killer-Cell LymphomaFive-year analysis from phase 2 trial of "sandwich" chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL).Aggressive natural killer-cell leukemia with jaundice and spontaneous splenic rupture: a case report and review of the literatureConsolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphomaEfficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma.Predictors of survival of natural killer/T-cell lymphoma, nasal type, in a non-Asian population: a single cancer centre experienceThe DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type.Diagnosis and management of natural killer-cell malignancies.Treatment algorithms for mature T-cell and natural killer-cell neoplasms.The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management.Diagnosis and management of rare gastrointestinal lymphomas.NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.Current and future management of NK/T-cell lymphoma based on clinical trials.Clinical study of l-asparaginase in the treatment of extranodal NK/T-cell lymphoma, nasal type.Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study.How to select the frontline treatment for a patient with peripheral T-cell lymphoma.Natural Killer T-Cell Lymphoma of the Orbit: An Evidence-Based Approach.Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy.The aggressive peripheral T-cell lymphomas: 2017.Clinicopathological analysis of 12 patients with Epstein-Barr virus-positive primary intestinal T/natural killer-cell lymphoma (EBV+ ITNKL).
P2860
Q27003257-1BA6F90D-C5C1-4541-B3FB-3DA9ECA04C6BQ27022519-3CB87C99-ECE9-466F-8BDA-98D8F9DFED2FQ30244110-09BDCE36-D791-4A1B-8CD6-9E6A5C2DC424Q30244553-E3A3C1DE-9A62-4014-85E0-AEDE59CEB25CQ33423016-3DDBE64F-B7CE-4184-A209-2B6885FFE983Q33429990-8C8D5DB0-BC2F-402E-A00A-ECC01CF7B343Q33433689-17055F54-4B68-43DE-9FFE-047BC2D4AF61Q33808534-19259A2D-5E01-4A84-B627-5D01529B157EQ34166857-6050ED33-D5DB-4110-9758-DC4119AC113FQ34479166-48715411-47CD-4503-9514-2C0AA402AF78Q35051804-A5310035-C02C-4BCE-9829-F64381020597Q35336213-267DE675-47FA-490B-A1EA-2BA6F588C54CQ35670806-2D9B23C5-471B-4804-B983-DBEC86646821Q36092555-6C83BC11-6333-45A5-BF73-184A8539E423Q36114075-60583AD6-4C39-425A-9A1A-FFF56F246B21Q36156508-4CEBDC15-C193-4C43-ACF4-77EE168259A8Q36232164-199E4B09-65E3-4896-A7E7-7989074A5180Q36331745-86679B90-7B1A-4E66-8840-5AB9732F31CDQ36368168-D69DFD67-139C-4872-A991-C4F39487B9DDQ36451579-DD396EF0-B9A2-4F10-93C5-E2B373A8EB81Q36517477-CF1872E2-2637-405D-A467-7BD230F6FE30Q36690830-ED54BB0C-A582-4E00-8F59-47BC5BBD4E16Q36760583-2ABC5662-DA2B-45A1-B9D0-18722EF0AC18Q37301747-A622C548-B177-4ECC-87C9-777D9B364592Q37458786-315FD55B-708F-436C-8B4E-37776CFFC8BAQ37629033-2F1CA12B-C01C-4338-86BA-55B66424AF3CQ37810280-1A1708FF-0ACF-4030-B215-1537915A7EB3Q37932546-7866CD44-3AAF-432E-9A15-0AD8FB8EAD47Q38003075-F82BF0F7-71AD-4AFD-95AE-B9BAFCA093B0Q38012167-6A0E9994-D429-4EBF-9D8E-0CF409D3A083Q38013696-96D879C0-2451-4F11-9C25-32EABE50FFB2Q38035410-87A1DE20-7244-4844-85FE-0C335097DC71Q38052819-355FC922-C205-44BB-8A69-95A8E729B376Q38433407-3A109330-5C1D-4439-BA16-D9FC6B319FCDQ38653148-24568706-A9DD-4AA5-9115-64E42955299EQ38724551-CA36C1C8-72D0-4661-93EE-96DAC3EB3295Q38980495-E51ADAF1-3827-46DF-8018-611370B0CC7EQ39038225-74A8E33A-0247-43DA-A9FE-CE94FFAA6797Q40197352-58F7C1C1-D273-4CFD-84CB-197C87A268BBQ40359227-3CC1DAB3-9327-48D8-BCF3-B459F339D54D
P2860
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prognostic factors for mature ...... l NK cell lymphoma, nasal type
@ast
Prognostic factors for mature ...... l NK cell lymphoma, nasal type
@en
Prognostic factors for mature ...... l NK cell lymphoma, nasal type
@nl
type
label
Prognostic factors for mature ...... l NK cell lymphoma, nasal type
@ast
Prognostic factors for mature ...... l NK cell lymphoma, nasal type
@en
Prognostic factors for mature ...... l NK cell lymphoma, nasal type
@nl
prefLabel
Prognostic factors for mature ...... l NK cell lymphoma, nasal type
@ast
Prognostic factors for mature ...... l NK cell lymphoma, nasal type
@en
Prognostic factors for mature ...... l NK cell lymphoma, nasal type
@nl
P2093
P3181
P356
P1433
P1476
Prognostic factors for mature ...... l NK cell lymphoma, nasal type
@en
P2093
J Suzumiya
K Iwatsuki
M Kurokawa
NK-cell Tumor Study Group
P304
P3181
P356
10.1093/ANNONC/MDP418
P407
P577
2009-10-22T00:00:00Z